Companies Dominating the Narcolepsy Drugs Landscape
- Ligand Pharmaceuticals Incorporated
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Jazz Pharmaceuticals Inc.
- Graymark Healthcare Inc.
- BIOPROJET
- Novartis AG
- Teva Pharmaceuticals Industries Ltd.
- Arena Pharmaceuticals Inc.
Browse Key Market Insights with Data Illustration:
In the News
- Ligand Pharmaceuticals Incorporated and GSK declared the Licence Agreement and the global growth of their relationship. The development is expected to be fueled by Icagen's particle discovery method and expertise in small-molecule therapeutics addressing membrane proteins.
- Teva Pharmaceutical Industries Ltd. stated that they would spend USD 69 million to settle a Narcolepsy drug lawsuit in California. The reimbursement is expected to help the corporation in maintaining its monopoly in an industry where the rival corporation's Narcolepsy drugs will postpone their release by nearly six months.
